This author has not written his bio yet.
But we are proud to say that Melanie Piontek contributed 41 entries already.
ARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidates using virus-like particles (VLP) presenting malaria transmission-stage antigens, which were capable of inducing transmission-blocking antibodies.
Meet us at the Bio-Europe Spring 2018 taking place in Vienna, Austria March 25 -27. Volker Jenzelewski, Director Technology at ARTES, will be present in the One-on-One Partnering presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products.
ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the University of Freiburg, Germany.
ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announced today the formation of a new strategic business pact, offering packet solution for biopharmaceutical processes . Aim of this new strategic business cooperation is to jointly out-license combinations of ARTES’ and Minapharm’s respective proprietary technologies and products to third parties […]
ARTES Biotechnology explored very effective in a SME consortium vaccine developments for veterinary applications. Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform and stable formulation especially suited for the veterinary applications, the EU cooperation was part of the 8th EuroTransBio call and was funded in the time period from […]
Meet us at the Bio-Europe Spring 2018 taking place in Amsterdam March 12 -14. Michael Piontek, Managing Director at ARTES, will be present in the One-on-One Partnering presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products. Contact us previously for organizing a personal meeting or drop us a […]
ARTES will attend February’s European Animal Health Investment Forum in London and will present its innovative technologies to potential partners This will be ARTES’ second participation in the high prestige investment networking event, which is seen as the ‘Dragons’ Den’ of veterinary medicine. ARTES Managing Director, Dr. Michael Piontek, will use the forum to talk […]
Meet us at the Biofit 2017 taking place in Strasbourg November 28 -29. Michael Piontek, Managing Director at ARTES, will be present in the One-on-One Partnering and we are present with our own booth (number F2). Contact us previously for organizing a personal meeting or drop us a notice via the partnering system. We look […]
ARTES Biotechnology GmbH today announced that it has just obtained governmental approval for ‘Crédit d’Impôt Recherche’ (CIR) for a three-year period from the French Ministry of Higher Education and Research (MESR). The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outsourced to ARTES’ […]
EU Research Project Nano3Bio sums up: Promising achievements for winning future raw materials Since fossil raw materials are rapidly running out, their substitution by renewable resources is becoming increasingly important. In this process, the biological production of raw materials will have to play a leading role. The international project Nano3Bio, including ARTES Biotechnology has contributed […]
